stocktools
Offerings // Radiopharm Theranostics Ltd

RADX offering history

Every offering-related filing in Radiopharm Theranostics Ltd’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 136 filings back to Dec 16, 2022.

Last executed offering
Jul 27, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Dec 17, 2025
F-3 — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 27, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 23, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 23, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 23, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 23, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 23, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 17, 2025F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 16, 2025F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 13, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 13, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 5, 2024F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Sep 18, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
RADX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full RADX workspace →
RADX offering FAQ

When did RADX last execute an offering?

Per SEC filings, Radiopharm Theranostics Ltd's most recent priced offering document is a 424B5 filed 2026-07-27. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did RADX last announce or register an offering?

The most recent registration is a F-3 filed 2025-12-17. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.